Big coffee interview with Professor Zhou Hu: The diagnosis and treatment of MDS still faces many challenges, and "standardization" is the top priority

Fenghua "Zheng" Mao, the exhibition "red" map, sponsored by the Chinese Medical Association and the Chinese Medical Association Hematology Branch, hosted by the Henan Provincial Medical Association, and co-organized by the First Affiliated Hospital of Zhengzhou University and the Second Hospital of Lanzhou University, the 18th National Conference on Red Blood Cell Disease (Anemia) was held

Medical Pulse Communication: With the continuous deepening of the understanding of MDS, the clinical diagnostic criteria are also changing

Medical Pulse Pass: Compared with lymphoma and leukemia, the progress of MDS treatment is relatively slow, can you please introduce what new drug progress in the MDS field is worth paying attention to in recent years?

Medical Pulse Pass: Combined with the current situation of MDS diagnosis and treatment in China, how do you think we should promote the standardized diagnosis and treatment of MDS in China?

Med: Could you please tell us about your vision for future MDS treatment?

Professor Zhou Hu

• Chief physician, professor, doctor of medicine, doctoral supervisor

• Deputy Director of the Department of Hematology, Henan Provincial Cancer Hospital

• Director of Anemia and Hemostatic Thrombotic Disease Area of Henan Provincial Cancer Hospital

• Director of Henan Hemostatic Thrombosis Diagnostic Research Engineering Center

• Leading talent of Henan Provincial Health Commission

• He is a member of the Hemostatic and Thrombotic Group of the Hematology Branch of the Chinese Medical Association

• He is a member of the Hematology Branch of the Chinese Geriatrics Association

• Member of the Special Committee on Hemostatic Thrombosis of the Chinese Physiological Society

• Member of the Blood Professional Committee of the Bethune Foundation

• Member of the Standing Committee of the Hemophilia Committee of the China Rare Disease Alliance

• Vice Chairman of the Hemostasis and Thrombotic Group of Henan Hematology Professional Committee

• Member of the editorial board of the journal "Thrombosis and Hemostasis", "BLOOD" Chinese edition

• He has presided over 2 projects of the National Natural Science Foundation of China and 1 key project of science and technology research of the Department of Education of Henan Province

• He is the chief editor of the monograph "Blood Fascicle / Internal Medicine Difficult Case Series" and other 5 books

Editor: Quinta

Review: Professor Zhou Hu

Typesetting: Quinta

Execution: Quarterly year

Poke "Read the original article" to see more